Established in 1945, Daewoong Pharmaceutical Co., Ltd. is one of the largest pharmaceutical company in Korea and envisions itself to become a top 50 global healthcare company by 2020. In order to become a global healthcare group company, Daewoong is expanding its global business with its foreign branches and global partners into whole Asia, including Indonesia using our localization strategy.

PT Daewoong Pharmaceutical Company Indonesia was established in 2005 as a subsidiary of Daewoong Pharmaceutical Co., Ltd. It has been contributing to the health of Indonesian Society by co-marketing of high quality medical devices and medicines, licensing and technology transfer with local company, and also education related.

Also in 2012, Daewoong and PT. Infion cooperate and established PT. Daewoong Infion by transfering technology and producing the first high quality Bio Pharmaceutical product for contribution to the development Bio Pharmaceutical Industry in Indonesia.

In the future, PT Daewoong Pharmaceutical Company Indonesia will continue to develop & enlarge its business to become The No.1 in Biotechnology of Pharmaceutical Industry and become part of Top 10 Pharmaceutical Companies in Indonesia.